Albavir - Abacavir 600 mg & Lamivudine 300 mg Tablets

Albavir Tablets contain abacavir 600 mg and lamivudine 300 mg, two established antiretroviral medicines used together as part of combination therapy for HIV infection. Both active ingredients belong to the nucleoside reverse transcriptase inhibitor (NRTI) class and work by interfering with HIV replication. Their combination provides a convenient dual-ingredient treatment option, supporting viral suppression and helping maintain immune-system function. The tablet formulation combines both medicines into a single oral dosage form, supporting convenient integration into a prescribed treatment regimen. Albavir can be incorporated into individualized HIV management plans under the supervision of qualified healthcare professionals, with treatment selected according to the patient’s clinical needs.